Estimating the Probability of Not Completing the Intended Course of Thoracic Radiotherapy for Lung Cancer.

Radiotherapy discontinuation of treatment lung cancer prognostic instrument risk factors

Journal

Anticancer research
ISSN: 1791-7530
Titre abrégé: Anticancer Res
Pays: Greece
ID NLM: 8102988

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 14 02 2022
revised: 25 02 2022
accepted: 28 02 2022
entrez: 29 3 2022
pubmed: 30 3 2022
medline: 5 4 2022
Statut: ppublish

Résumé

In some patients with lung cancer scheduled for thoracic radiotherapy (RT), treatment is discontinued before reaching the planned dose. For optimal treatment personalization, a tool estimating whether a patient can complete radiotherapy would be helpful. Eleven pre-RT characteristics were analyzed in 170 patients receiving local RT for lung cancer. Characteristics included age, sex, tumor site, histology, tumor and nodal stage, distant metastasis, surgery, systemic treatment, pulmonary function, and smoking history. Age >75 years (p=0.038), distant metastasis (p=0.009), and forced expiratory volume in 1 second <1.2 l (p=0.038) were significantly associated with discontinuation of RT. A prognostic instrument was developed in 126 patients with complete data regarding these characteristics. It included three groups (0, 1, and 2-3 points) with non-completion rates of 33.3%, 55.0% and 75.0% (p=0.004). This new instrument can help estimating the probability that lung cancer patients assigned to local RT cannot complete the planned course of RT.

Sections du résumé

BACKGROUND/AIM OBJECTIVE
In some patients with lung cancer scheduled for thoracic radiotherapy (RT), treatment is discontinued before reaching the planned dose. For optimal treatment personalization, a tool estimating whether a patient can complete radiotherapy would be helpful.
PATIENTS AND METHODS METHODS
Eleven pre-RT characteristics were analyzed in 170 patients receiving local RT for lung cancer. Characteristics included age, sex, tumor site, histology, tumor and nodal stage, distant metastasis, surgery, systemic treatment, pulmonary function, and smoking history.
RESULTS RESULTS
Age >75 years (p=0.038), distant metastasis (p=0.009), and forced expiratory volume in 1 second <1.2 l (p=0.038) were significantly associated with discontinuation of RT. A prognostic instrument was developed in 126 patients with complete data regarding these characteristics. It included three groups (0, 1, and 2-3 points) with non-completion rates of 33.3%, 55.0% and 75.0% (p=0.004).
CONCLUSION CONCLUSIONS
This new instrument can help estimating the probability that lung cancer patients assigned to local RT cannot complete the planned course of RT.

Identifiants

pubmed: 35347017
pii: 42/4/1973
doi: 10.21873/anticanres.15675
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1973-1977

Informations de copyright

Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Auteurs

Dirk Rades (D)

Department of Radiation Oncology, University of Lübeck, Lübeck, Germany; dirk.rades@uksh.de.

Esther Glatzel (E)

Department of Radiation Oncology, University of Lübeck, Lübeck, Germany.

Sabine Bohnet (S)

Department of Pulmonology, University of Lübeck, Lübeck, Germany.

Steven E Schild (SE)

Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.

Elisa M Werner (EM)

Department of Radiation Oncology, University of Lübeck, Lübeck, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH